Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc. (ARCT) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ARCT · as of Jun 8, 2026
Activity summary
Buy transactions
2
P-Purchase only
Sell transactions
1
12 Months
Buy/Sell ratio
2.00
Buy/Sell (by trades)
Overall sentiment
Arcturus Therapeutics Holdings Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
ARCT insider buying and selling by quarter
ARCT insider selling · ARCT insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · ARCT ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ARCT executive sell shares · ARCT board member insider trading · ARCT insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 15, 2025 | SASSINE ANDY CFO · Director | Purchase | 1,238 | $20K | Form 4 |
| Oct 15, 2024 | Chivukula Pad Chief Scientific Officer & COO | Sale | 12,000 | $249K | Form 4 |
| Jun 14, 2024 | Marantz Jing L. Director | Option | 3,131 | — | Form 4 |
| Jun 14, 2024 | HOLMES EDWARD W Director | Option | 3,131 | — | Form 4 |
| Jun 14, 2024 | Markels John Director | Option | 3,131 | — | Form 4 |
| Jun 14, 2024 | Marquet Magda Director | Option | 3,131 | — | Form 4 |
| Jun 14, 2024 | BARLOW JAMES F Director | Option | 3,131 | — | Form 4 |
| Jun 14, 2024 | FARRELL PETER C Director | Option | 3,131 | — | Form 4 |
| Jun 12, 2024 | SASSINE ANDY CFO · Director | Sale | 50,000 | $1.60M⚡ | Form 4 |
| Jun 5, 2024 | Chivukula Pad Chief Scientific Officer & COO | Sale | 114 | $5K | Form 4 |
| Jun 3, 2024 | Chivukula Pad Chief Scientific Officer & COO | Sale | 26,000 | $1.04M⚡ | Form 4 |
| Mar 25, 2024 | Chivukula Pad Chief Scientific Officer & COO | Sale | 17,435 | $611K | Form 4 |
| Mar 19, 2024 | Chivukula Pad Chief Scientific Officer & COO | Sale | 8,565 | $300K | Form 4 |
| Nov 1, 2023 | Chivukula Pad Chief Scientific Officer & COO | Sale | 5,000 | $94K | Form 4 |
| Oct 2, 2023 | Chivukula Pad Chief Scientific Officer & COO | Sale | 5,000 | $128K | Form 4 |
| Sep 1, 2023 | Chivukula Pad Chief Scientific Officer & COO | Sale | 5,000 | $157K | Form 4 |
| Aug 15, 2023 | SASSINE ANDY CFO · Director | Award | 1,223 | $21K | Form 4 |
| Aug 1, 2023 | Chivukula Pad Chief Scientific Officer & COO | Sale | 5,000 | $175K | Form 4 |
| Jul 14, 2023 | Chivukula Pad Chief Scientific Officer & COO | Sale | 25,000 | $875K | Form 4 |
| Jul 14, 2023 | Kummerfeld Keith C See Remarks | Option | 1,031 | $15K | Form 4 |
| Jul 14, 2023 | Kummerfeld Keith C See Remarks | Option | 1,437 | $7K | Form 4 |
| Jul 14, 2023 | Kummerfeld Keith C See Remarks | Option | 4,500 | $41K | Form 4 |
| Jul 14, 2023 | Kummerfeld Keith C See Remarks | Sale | 6,968 | $244K | Form 4 |
| Jul 3, 2023 | Chivukula Pad Chief Scientific Officer & COO | Sale | 5,000 | $144K | Form 4 |
| Jun 1, 2023 | Chivukula Pad Chief Scientific Officer & COO | Sale | 5,000 | $136K | Form 4 |
Chivukula Pad
Chief Scientific Officer & COO
Date
Oct 15
Shares
12,000
Price
$20.76
Value
$249K
Chivukula Pad
Chief Scientific Officer & COO
Date
Jun 5
Shares
114
Price
$45.00
Value
$5K
Chivukula Pad
Chief Scientific Officer & COO
Date
Jun 3
Shares
26,000
Price
$40.01
Value
$1.04M ⚡
Chivukula Pad
Chief Scientific Officer & COO
Date
Mar 25
Shares
17,435
Price
$35.02
Value
$611K
Chivukula Pad
Chief Scientific Officer & COO
Date
Mar 19
Shares
8,565
Price
$35.01
Value
$300K
Chivukula Pad
Chief Scientific Officer & COO
Date
Nov 1
Shares
5,000
Price
$18.72
Value
$94K
Chivukula Pad
Chief Scientific Officer & COO
Date
Oct 2
Shares
5,000
Price
$25.61
Value
$128K
Chivukula Pad
Chief Scientific Officer & COO
Date
Sep 1
Shares
5,000
Price
$31.45
Value
$157K
Chivukula Pad
Chief Scientific Officer & COO
Date
Aug 1
Shares
5,000
Price
$34.91
Value
$175K
Chivukula Pad
Chief Scientific Officer & COO
Date
Jul 14
Shares
25,000
Price
$35.01
Value
$875K
Chivukula Pad
Chief Scientific Officer & COO
Date
Jul 3
Shares
5,000
Price
$28.75
Value
$144K
Chivukula Pad
Chief Scientific Officer & COO
Date
Jun 1
Shares
5,000
Price
$27.16
Value
$136K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ARCT insider trading
ARCT insider trades
Arcturus Therapeutics Holdings Inc. (ARCT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including SASSINE ANDY (CFO · Director). Over the past 12 months, 1 insiders have filed transactions with the SEC. ARCT insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Arcturus Therapeutics Holdings Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ARCT insider trading · 5 questionsThe insiders of Arcturus Therapeutics Holdings Inc. (ARCT) include executives and directors such as SASSINE ANDY (CFO · Director), among others. Over the past 12 months, 1 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026